| Literature DB >> 35160997 |
Lăcrămioara Popa1, Mihaela Violeta Ghica1, Elena-Emilia Tudoroiu1, Diana-Georgiana Ionescu1, Cristina-Elena Dinu-Pîrvu1.
Abstract
Nowadays, the development of new eco-friendly and biocompatible materials using 'green' technologies represents a significant challenge for the biomedical and pharmaceutical fields to reduce the destructive actions of scientific research on the human body and the environment. Thus, bacterial cellulose (BC) has a central place among these novel tailored biomaterials. BC is a non-pathogenic bacteria-produced polysaccharide with a 3D nanofibrous structure, chemically identical to plant cellulose, but exhibiting greater purity and crystallinity. Bacterial cellulose possesses excellent physicochemical and mechanical properties, adequate capacity to absorb a large quantity of water, non-toxicity, chemical inertness, biocompatibility, biodegradability, proper capacity to form films and to stabilize emulsions, high porosity, and a large surface area. Due to its suitable characteristics, this ecological material can combine with multiple polymers and diverse bioactive agents to develop new materials and composites. Bacterial cellulose alone, and with its mixtures, exhibits numerous applications, including in the food and electronic industries and in the biotechnological and biomedical areas (such as in wound dressing, tissue engineering, dental implants, drug delivery systems, and cell culture). This review presents an overview of the main properties and uses of bacterial cellulose and the latest promising future applications, such as in biological diagnosis, biosensors, personalized regenerative medicine, and nerve and ocular tissue engineering.Entities:
Keywords: bacterial cellulose; biomedical applications; composites; ecological biopolymer; tissue engineering; wound dressing
Year: 2022 PMID: 35160997 PMCID: PMC8839122 DOI: 10.3390/ma15031054
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
Figure 1The microscopic cytoplasm synthesis of bacterial cellulose.
Figure 2The advantages of bacterial cellulose.
Figure 3A schematic illustration of a bacterial cellulose composite.
Figure 4The major applications of bacterial cellulose-based composites.
Biomedical applications of bacterial cellulose.
| Anatomical Part | Tissue Type | Application | Composition | Qualitative Properties | References |
|---|---|---|---|---|---|
| Skin | Epithelial tissue (soft tissue) | Wound restorative therapy | BC-modified topography | Wound healing enhancement: collagen migration enabled at the wound site along with fibroblast infiltration | [ |
| BC-CuO membrane | Proper antimicrobial activity against | [ | |||
| TEMPO-oxidized BC-AgNPs | Antimicrobial activity with 12% Ag release rates (37 °C). | [ | |||
| BC-TiO2 | Antibacterial activity against | [ | |||
| BC-AgNPs nanocomposite | Antibacterial activity against | [ | |||
| BC-ZnO nanocomposite | Antibacterial activity against | [ | |||
| BC-propolis extract | Anti-inflammatory, antibacterial activity, and antioxidant functions on diabetic wounds | [ | |||
| BC-phenolic acids membranes | Suitable anti-inflammatory and antioxidant effects; non-cytotoxicity | [ | |||
| Periodate oxidized BC-chloramphenicol | Antibacterial spectrum, biodegradable, and biocompatible | [ | |||
| BC-vaccarin | [ | ||||
| BC-diethyldithiocarbamate | OH-slow releasing systems: parasitic-caused lesion size reduction, SOD inhibition | [ | |||
| BC-ε-poly- | Extended antimicrobial spectrum | [ | |||
| BC-acrylic acid hydrogel | Promoter of complete healing of wounds: water absorption and retention with good mechanical properties. | [ | |||
| BC-poly-methyl methacrylate | Biodegradable bandages, which support wound healing | [ | |||
| BC-Octenidine-Poloxamer | Ready to use topical drug delivery systems: controlled release of active substances, effective for infected wounds | [ | |||
| BC-acrylic acid-human keratocytes and dermal fibroblasts hydrogel | Same wound healing properties as plain BC and a prolific cell carrier | [ | |||
| Enzymatic degradative biomaterials for surgical sutures | BC nanocrystals-regenerated chitin fibers | Wound healing enhancer with adaptable degradation rate (chitin concentration), biodegradable, strong suture material | [ | ||
| Tissue restoration | BC-tuned porosity | Muscle cell growth enhanced due to pore diameter, but slight strength reduction | [ | ||
| BC membrane | Appropriate nanomorphological properties, optimal control of infection, capacity to retain moisture; adequate drug delivery system | [ | |||
| BC-PHEMA hydrogel matrices | Mesenchymal stem cells proliferation proven in rats | [ | |||
| Connective tissue | Active ingredients for transdermal release | BC-chloro-aluminum phthalocyanine membrane | Skin cancer: delivery system for photodynamic therapy with adequate properties for topical administration | [ | |
| BC-lidocaine/ibuprofen membrane | Possibility of drug bioavailability modulation-dermal administration of lidocaine and ibuprofen | [ | |||
| Dressing materials | Modified BC-chitosan | Abdominal hernia treatment-reduced chance of infections caused by the mesh, no irritation, no hypersensitivity at implant site | [ | ||
| BC-sericin-PHMB film | Healing acceleration: low inflammatory response, high degree of collagen formation, scar shrinkage | [ | |||
| BC-alginate-gelatin film | Optimal ductility, biocompatibility, increased flexibility, and capacity to absorb water. | [ | |||
| Blood vessels | Connective tissue | Restoration replacement | BC-Fe3O4NPs magnetic pellicle | Small capillarity blood vessels | [ |
| Biosynthetic blood vessels | BC-polyglycolic acid and expanded polytetrafluorethylene | Biocompatibility (absence of leukocyte activation), apoptotic cell absence, vascularized granulation tissue, and multiple proliferating cells | [ | ||
| Engineered vessels with anticoagulant property | BC-heparin nanofibrous scaffold | Anticoagulant properties-sulphate groups-enriched BC-heparin hybrid | [ | ||
| Blood cloth control | BC from nata de coco-kaolin | Topographical properties and malleability of the biomaterial exceed the attraction forces between clotted blood proteins | [ | ||
| Vascular embolization: interventional therapies | BC-poly-N-isopropyl acrylamide-co-butyl methacrylate nanogel | Thermosensitive injectable biomaterials: expanded to condensed gel state | [ | ||
| Aortic heart valve | Connective tissue | Prospective replacement therapy | BC-PVA hydrogel | Biomimicry: non-linear mechanical properties | [ |
| Cartilages | Connective tissue | Replacement, reconstruction | BC-poly(dimethyl acrylamide) double network gel | Meets properties of artificial cartilage; no in vivo tests confirmation | [ |
| BC-PVA composite | Proven elasticity and similar properties to native cartilages | [ | |||
| Osteochondral defect treatment | Bilayer BC-hydroxyapatite and BC-glycosaminoglycan indice | Accelerated recovery of articular cartilage and subchondral bone in model rats with osteochondral defects | [ | ||
| Bone | Skeletal tissue | Advanced regeneration | BC-bone mesenchymal protein-2 scaffolds | Osteogenesis in rat ectopic models | [ |
| Regeneration, reconstruction | BC-Fisetin scaffold indice | Bone matrix induced biosynthesis | [ | ||
| Gums and | Connective tissue | Early stages of regeneration | BC-hydroxyapatite-osteogenic growth peptide nanocomposite | Osteoblast differentiation | [ |
| Tooth extraction or transplantation of oral mucosa | Native and oxidized BC-doxycycline | Dental dressings with potential of biodegradability, antimicrobial activity against pathogenic oral bacteria, and suitable drug delivery system | [ | ||
| Periodontal tissue recovery after dental implants | Inner membrane of BC and external alkali-cellulose (Gengiflex®) | Osseo-deficiency treatment: inflammatory response diminished, reduced number of surgical steps, restoration of mouth functions, and aesthetic role | [ | ||
| Eye | Corneal epithelial tissue | Artificial corneal biomaterial | BC/PVA hydrogel | Suitable water content, high visible light transmittance, UV absorbance, proper strength, and thermal properties | [ |
| Retinal pigment epithelium (RPE) | Transplant | Acetylated BC-urinary bladder matrix | Appropriate features as cell carriers in potential RPE transplantation | [ | |
| Gastro-intestinal level | Connective and epithelial tissues | Drug delivery system | BC-polyacrylic acid-bovine albumin (various concentration) hydrogel | Optimization of drug release rate: pH dependent (similar to plain BC membranes) | [ |
Abbreviations: AgNPs—Silver (Ag) nanoparticles, CuO—Copper oxide, Fe3O4NPs—Iron oxide nanoparticles, PHEMA—Poly(2-hydroxyethyl methacrylate), PHMB—Polyhexamethylene biguanide, PVA—Poly(vinyl alcohol), SOD—Superoxide dismutase, TEMPO-oxidized (2,2,6,6-tetramethyl piperidine oxide), TiO2—Titanium Dioxide, ZnO—Zinc oxide.